Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Cigna (CI) and Genmab (GMAB)

TipRanksMay 3 19:38

Genmab (GMAB) Receives a Buy From Truist Financial

TipRanksMay 3 19:30

Optimistic Outlook for Genmab: Strategic Growth and Product Performance Underpin Buy Rating

TipRanksMay 3 19:00

Earnings Call Summary | Genmab(GMAB.US) Q1 2024 Earnings Conference

The following is a summary of the Genmab A/S (GMAB) Q1 2024 Earnings Call Transcript:Financial Performance:Genmab reported strong growth across its portfolio in Q1 2024, with notable gain in DARZALEX

Futu NewsMay 3 16:50 · Conference Call

Genmab Posts Q1 Net Profit Surge; Revenue Jumps

Genmab (GMAB.CO) said Thursday net profit for the first quarter surged as revenue jumped year over year. Net profit for the three months ended March 31 was 1.33 billion Danish kroner, compared with 21

MT NewswiresMay 3 10:48

Genmab (GMAB.US): The 2024 Q1 financial report achieved revenue of US$600.4 million, previous value of US$411.3 million, expected value of US$577.5 million; earnings per share were US$0.29, previous value was US$0.05, and expected value was US$0.14.

Genmab (GMAB.US): The 2024 Q1 financial report achieved revenue of US$600.4 million, previous value of US$411.3 million, expected value of US$577.5 million; earnings per share were US$0.29, previous value was US$0.05, and expected value was US$0.14.

Zhitong FinanceMay 3 00:40